Par Pharmaceutical, Inc., Alkermes Pharma Ireland Limited v. Twi Pharmaceuticals, Inc.

N OTE: This disposition is nonprecedential.
United States Court of Appeals
for the Federal Circuit
______________________
PAR PHARMACEUTICAL, INC., ALKERMES
PHARMA IRELAND LIMITED,
Plaintiffs-Appellants
v.
TWI PHARMACEUTICALS, INC.,
Defendant-Appellee
______________________
2015-1880
______________________
Appeal from the United States District Court for the
District of Maryland in No. 1:11-cv-02466-CCB, Judge
Catherine C. Blake.
______________________
JUDGMENT
______________________
D ANIEL BROWN, Latham & Watkins LLP, New York,
NY, argued for plaintiffs-appellants. Plaintiff-appellant
Par Pharmaceutical, Inc., also represented by ROGER J.
CHIN, G REGORY SOBOLSKI, San Francisco, CA; J ONATHAN
Y. ELLIS , G REGORY G. G ARRE , MICHAEL J. G ERARDI, Wash-
ington, DC; J AMES PATRICK U LWICK, Kramon and Gra-
ham, P.A., Baltimore, MD.

-- 1 of 2 --

MARYELLEN N OREIKA, Morris, Nichols, Arsht & Tun-
nell LLP, Wilmington, DE, for plaintiff-appellant Alker-
mes Pharma Ireland Limited. Also represented by J ACK B.
BLUMENFELD, J EREMY A. T IGAN; J AMES P ATRICK U LWICK,
Kramon and Graham, P.A., Baltimore, MD.
D ONALD J. MIZERK, Husch Blackwell LLP, Chicago,
IL, argued for defendant-appellee. Also represented by
P HILIP D ALE SEGREST , J R., J OHN A. SHOLAR, J R.
______________________
T HIS CAUSE having been heard and considered, it is
O RDERED and A DJUDGED:
P ER CURIAM (O’MALLEY , P LAGER , and WALLACH ,
Circuit Judges).
AFFIRMED. See Fed. Cir. R. 36.
ENTERED BY O RDER OF THE COURT
December 15, 2015 /s/ Daniel E. O’Toole
Date Daniel E. O’Toole
Clerk of Court

-- 2 of 2 --